Performance funds/ETFs

The fund invests in equities of companies operating in the medical biotechnology sector. It may invest worldwide including in emerging markets and Mainland China, although most of investments are concentrated in western countries. It invests in companies whose activities are related to, but not limited to, new mechanisms of actions offering potential cures or management of diseases that were hard to treat before, technology platforms, research tools and services in the biotechnology value chain as well as the improvement of therapies or drugs.